Back
Zevra Therapeutics, Inc. Stock Price Chart
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
39
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.60
Seasonality Move:
-4.54%
7 Day Trial
ALL ACCESS PASS
$
7
This Company Solves Remote Work with Virtual HQs
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight selling pressure.
Zevra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.86 | Sell |
| 20-day SMA: | 8.89 | Sell |
| 50-day SMA: | 8.65 | Sell |
| 200-day SMA: | 9.32 | Sell |
| 8-day EMA: | 6.85 | Buy |
| 20-day EMA: | 4 | Buy |
| 50-day EMA: | 1.9 | Buy |
| 200-day EMA: | 0.52 | Buy |
Zevra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.31 | Buy |
| Relative Strength Index (14 RSI): | 45.76 | Sell |
| Chaikin Money Flow: | -57013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.49 - 9.11) | Sell |
| Bollinger Bands (100): | (8.23 - 10.15) | Sell |
Zevra Therapeutics, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics, Inc. Stock
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.60 while ZVRA 8-day simple moving average is 8.86, which is a Sell signal.
-
The stock price of ZVRA is 8.60 while Zevra Therapeutics, Inc. 20-day SMA is 8.89, which makes it a Sell.
-
Zevra Therapeutics, Inc. 50-day simple moving average is 8.65 while ZVRA share price is 8.60, making it a Sell technically.
-
ZVRA stock price is 8.60 and Zevra Therapeutics, Inc. 200-day simple moving average is 9.32, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. a Buy or a Sell?
-
Zevra Therapeutics, Inc. stock is rated a SellThe current Zevra Therapeutics, Inc. [ZVRA] share price is $8.60. The Score for ZVRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics, Inc. Stock Info
Market Cap:
484.2M
Price in USD:
8.60
Share Volume:
604.3K
Zevra Therapeutics, Inc. 52-Week Range
52-Week High:
13.16
52-Week Low:
6.19
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Zevra Therapeutics, Inc. Share Price Forecast
-
What is the Zevra Therapeutics, Inc. stock price today?The Zevra Therapeutics, Inc. stock price is 8.60 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics, Inc. is overvalued.
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.60 while ZVRA 8-day exponential moving average is 6.85, which is a Buy signal.
-
The stock price of ZVRA is 8.60 while Zevra Therapeutics, Inc. 20-day EMA is 4.00, which makes it a Buy.
-
Zevra Therapeutics, Inc. 50-day exponential moving average is 1.90 while ZVRA share price is 8.60, making it a Buy technically.
-
ZVRA stock price is 8.60 and Zevra Therapeutics, Inc. 200-day simple moving average is 0.52, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics, Inc.
Is Zevra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $1.12 per share.
Technical Analysis of Zevra Therapeutics, Inc.
Should I short Zevra Therapeutics, Inc. stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 2.31, suggesting Zevra Therapeutics, Inc. is a Buy
-
Zevra Therapeutics, Inc. Relative Strength Index (RSI) is 45.76, which suggest Zevra Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics, Inc. is (8.49 - 9.11), which suggest Zevra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics, Inc. is (8.23 - 10.15), which suggest Zevra Therapeutics, Inc. is a Sell
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.